Crossmark

Development of a Dosage Form of the New Antitumor Antibiotic Olivamide

Crossref DOI link: https://doi.org/10.1007/s11094-019-01928-x

Published Online: 2019-02-12

Published Print: 2019-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tevyashova, A. N.

Bychkova, E. N.

Dezhenkova, L. G.

Shchekotikhin, A. E.
License Information

Text and Data Mining valid from 2019-02-12

Version of Record valid from 2019-02-12
More Information

Article History

Received: 30 June 2018

First Online: 12 February 2019